DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Konkle B, Young G, Liesner R. et al.
Long-term efficacy and safety of prophylactic treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with severe haemophilia A: final longitudinal analysis of A-LONG/ kids A-LONG and ASPIRE.
Haemophilia 2019;
25 (Suppl. 01) 55
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.